SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007470
Filing Date
2019-08-07
Accepted
2019-08-07 16:13:35
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20190630x10q.htm   iXBRL 10-Q 2042387
2 EX-31.1 edit-20190630ex311726053.htm EX-31.1 19691
3 EX-31.2 edit-20190630ex3121f8e20.htm EX-31.2 19216
4 EX-32.1 edit-20190630ex321bdf4bd.htm EX-32.1 13504
  Complete submission text file 0001558370-19-007470.txt   6860469

Data Files

Seq Description Document Type Size
5 EX-101.SCH edit-20190630.xsd EX-101.SCH 42214
6 EX-101.CAL edit-20190630_cal.xml EX-101.CAL 50872
7 EX-101.DEF edit-20190630_def.xml EX-101.DEF 145360
8 EX-101.LAB edit-20190630_lab.xml EX-101.LAB 424206
9 EX-101.PRE edit-20190630_pre.xml EX-101.PRE 309526
10 EXTRACTED XBRL INSTANCE DOCUMENT edit-20190630x10q_htm.xml XML 1154597
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 191005598
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences